ARS Investment Partners’s Prelude Therapeutics PRLD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,400	Closed	-$212K	–	170
2021 Q2	$212K	Hold	7,400	–	–	0.02%	134
2021 Q1	$321K	Hold	7,400	–	–	0.04%	113
2020 Q4	$529K	Buy	+7,400	New	+$529K	0.07%	82